Project

A Phase I and stratified, multicenter Phase II trial of trans-dermal CR1447 (4-OH-testosterone) in endocrine respon-sive-HER2 negative and triple negative-androgen receptor positive metastatic or locally advanced breast cancer

Automatically Closed · 2014 until 2017

Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Automatically Closed
Start Date
2014
End Date
2017
Financing
Others
Study Design
Phase I/II
Keywords
Phase I, Phase II, CR1447, 4-OH-testosterone, breast cancer
Brief description/objective

Neue Therapieoption durch endokrin wirksame Substanz bei Mammakarzinom. Neue Applikationsart als Crème, potentiell gut verträglich. Weitere endokrine Therapielinie bei Progress unter Aromataseinhibitoren, mögliche Thera-pieoption bei TNBC.